IOVA vs MSFT: Which Stock is Better?
Side-by-side comparison of Iovance Biotherapeutics Inc and Microsoft Corporation in 2026
IOVA
Iovance Biotherapeutics Inc
$8.30
MSFT
Microsoft Corporation
$495.83
Key Metrics Comparison
| Metric | IOVA | MSFT | Winner |
|---|---|---|---|
| Market Cap | $1.89B | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | MSFT |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 0.0% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze IOVA
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IOVA or MSFT a better investment?
Comparing IOVA and MSFT: Iovance Biotherapeutics Inc has a market cap of $1.89B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IOVA and MSFT?
IOVA (Iovance Biotherapeutics Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IOVA or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IOVA or MSFT?
MSFT has higher revenue growth at 18.4% vs 0.0% for IOVA.
Which company is more profitable: IOVA or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for IOVA.
Which is the larger company: IOVA or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $1.89B for IOVA.
Should I buy IOVA or MSFT in 2026?
Both IOVA and MSFT have investment merit. IOVA trades at $8.30 while MSFT trades at $495.83. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IOVA and MSFT stock?
Key differences: Market Cap ($1.89B vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (0.0% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy IOVA or MSFT in 2026?
The choice between IOVA and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between IOVA and MSFT?
IOVA (Iovance Biotherapeutics Inc) has a market cap of $1.89B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.